216 related articles for article (PubMed ID: 36650516)
1. Payment systems for dialysis and their effects: a scoping review.
Emrani Z; Amiresmaili M; Daroudi R; Najafi MT; Akbari Sari A
BMC Health Serv Res; 2023 Jan; 23(1):45. PubMed ID: 36650516
[TBL] [Abstract][Full Text] [Related]
2. Payment methods for outpatient care facilities.
Yuan B; He L; Meng Q; Jia L
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011153. PubMed ID: 28253540
[TBL] [Abstract][Full Text] [Related]
3. Managing oral phosphate binder medication expenditures within the Medicare bundled end-stage renal disease prospective payment system: economic implications for large U.S. dialysis organizations.
Park H; Rascati KL; Keith MS
J Manag Care Spec Pharm; 2015 Jun; 21(6):507-14. PubMed ID: 26011552
[TBL] [Abstract][Full Text] [Related]
4. Medicare Program; End-Stage Renal Disease Prospective Payment System, Coverage and Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program Bid Surety Bonds, State Licensure and Appeals Process for Breach of Contract Actions, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program and Fee Schedule Adjustments, Access to Care Issues for Durable Medical Equipment; and the Comprehensive End-Stage Renal Disease Care Model. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2016 Nov; 81(214):77834-969. PubMed ID: 27905888
[TBL] [Abstract][Full Text] [Related]
5. Financial implications to Medicare from changing the dialysis modality mix under the bundled prospective payment system.
Liu FX; Walton SM; Leipold R; Isbell D; Golper TA
Perit Dial Int; 2014; 34(7):749-57. PubMed ID: 25292402
[TBL] [Abstract][Full Text] [Related]
6. Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, and End-Stage Renal Disease Quality Incentive Program. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2017 Nov; 82(210):50738-97. PubMed ID: 29091373
[TBL] [Abstract][Full Text] [Related]
7. Need for an incentive-based reimbursement policy toward quality care for dialysis patient management.
Hidai H
Kidney Int; 2000 Jul; 58(1):363-73. PubMed ID: 10886583
[TBL] [Abstract][Full Text] [Related]
8. The ESRD Quality Incentive Program-Can We Bridge the Chasm?
Weiner D; Watnick S
J Am Soc Nephrol; 2017 Jun; 28(6):1697-1706. PubMed ID: 28298324
[TBL] [Abstract][Full Text] [Related]
9. Calcimimetic Use in Dialysis-Dependent Medicare Fee-for-Service Beneficiaries and Implications for Bundled Payment.
Gooding M; Desai P; Owens H; Petrilla AA; Kambhampati M; Levine Z; Young J; Fagan J; Rubin R
Kidney360; 2020 Oct; 1(10):1091-1098. PubMed ID: 35368776
[TBL] [Abstract][Full Text] [Related]
10. Converting to a capitation system for dialysis payment--the Portuguese experience.
Ponce P; Marcelli D; Guerreiro A; Grassmann A; Gonçalves C; Scatizzi L; Bayh I; Stopper A; Da Silva R
Blood Purif; 2012; 34(3-4):313-24. PubMed ID: 23306519
[TBL] [Abstract][Full Text] [Related]
11. Financial implications of choice of dialysis type of the revised Medicare payment system: an economic analysis.
Hornberger J; Hirth RA
Am J Kidney Dis; 2012 Aug; 60(2):280-7. PubMed ID: 22560829
[TBL] [Abstract][Full Text] [Related]
12. Medical ethics: enhanced or undermined by modes of payment?
Zweifel P; Janus K
Eur J Health Econ; 2017 Jan; 18(1):119-129. PubMed ID: 27072055
[TBL] [Abstract][Full Text] [Related]
13. Projected impact of the proposed "bundled" ESRD payment system on a small dialysis organization.
Bhat P; Sokolowski W; Bhat JG
Nephrol News Issues; 2009 Jun; 23(7):46, 48-52. PubMed ID: 19585810
[TBL] [Abstract][Full Text] [Related]
14. The initial impact of Medicare's new prospective payment system for kidney dialysis.
Hirth RA; Turenne MN; Wheeler JR; Nahra TA; Sleeman KK; Zhang W; Messana JA
Am J Kidney Dis; 2013 Oct; 62(4):662-9. PubMed ID: 23769138
[TBL] [Abstract][Full Text] [Related]
15. Effect of Medicare dialysis payment reform on use of erythropoiesis stimulating agents.
Swaminathan S; Mor V; Mehrotra R; Trivedi AN
Health Serv Res; 2015 Jun; 50(3):790-808. PubMed ID: 25355431
[TBL] [Abstract][Full Text] [Related]
16. Association of the Comprehensive End-Stage Renal Disease Care Model With Medicare Payments and Quality of Care for Beneficiaries With End-Stage Renal Disease.
Marrufo G; Colligan EM; Negrusa B; Ullman D; Messana J; Shah A; Duvall T; Hirth RA
JAMA Intern Med; 2020 Jun; 180(6):852-860. PubMed ID: 32227133
[TBL] [Abstract][Full Text] [Related]
17. Payment Reform and Health Disparities: Changes in Dialysis Modality under the New Medicare Dialysis Payment System.
Turenne M; Baker R; Pearson J; Cogan C; Mukhopadhyay P; Cope E
Health Serv Res; 2018 Jun; 53(3):1430-1457. PubMed ID: 28560726
[TBL] [Abstract][Full Text] [Related]
18. What can we learn from the U.S. expanded end-stage renal disease bundle?
Chambers JD; Weiner DE; Bliss SK; Neumann PJ
Health Policy; 2013 May; 110(2-3):164-71. PubMed ID: 23419419
[TBL] [Abstract][Full Text] [Related]
19. The effect of financial incentives on the quality of health care provided by primary care physicians.
Scott A; Sivey P; Ait Ouakrim D; Willenberg L; Naccarella L; Furler J; Young D
Cochrane Database Syst Rev; 2011 Sep; (9):CD008451. PubMed ID: 21901722
[TBL] [Abstract][Full Text] [Related]
20. Paying for performance to improve the delivery of health interventions in low- and middle-income countries.
Diaconu K; Falconer J; Verbel A; Fretheim A; Witter S
Cochrane Database Syst Rev; 2021 May; 5(5):CD007899. PubMed ID: 33951190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
